Sex steroid regulation of growth hormone secretion and action

Hormone Research in Paediatrics

Volumn 45, Issue 1-2, 1996, Pages 67-73

  Ho, Ken K Y ^a   O’Sullivan, Anthony J ^a   Weissberger, Andrew J ^a   Kelly, John J ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

Growth hormone; Insulin like growth factor 1; Menopause; Oestrogen; Sex steroids

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; CONJUGATED ESTROGEN; ESTRADIOL; ESTRADIOL VALERATE; ESTROGEN; ETHINYLESTRADIOL; GROWTH HORMONE; OSTEOCALCIN; SEX HORMONE; SOMATOMEDIN C;

ADULT; AGING; BONE; CLINICAL ARTICLE; CONFERENCE PAPER; CONNECTIVE TISSUE; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; MENOPAUSE; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; SEX DIFFERENCE; TRANSDERMAL DRUG ADMINISTRATION;

ADULT; ANIMALS; ESTRADIOL; ESTROGENS; FEMALE; GROWTH HORMONE; HOMEOSTASIS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LIVER; MALE; POSTMENOPAUSE; SEX CHARACTERISTICS; STEROIDS;

EID: 0030024474     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000184762     Document Type: Article

References (53)

1. Rose SR, Municchi CI, Barnes KM, Kamp G A, Uriarte MM, Ross JL, Cassorla F, Tiller GB: Spontaneous growth hormone secretion increases during puberty in normal girls and boys, J Clin Endocrinol Melab 1991:73: 428-435.
2. Martha PM Jr, Gorman KM, Blizzard RM, Rogol AD, Veldhuis JD: Endogenous growth hormone secretion and clearance rates in normal boys, as determined by deconvolution analysis: Relation to age, pubertal status and body mass, J Clin Endocrinol Mclab 1992:74: 336-344.
3. Martha PM Jr, Rogol AD, Veldhuis JD, Kerrigan JR, Goodman DW, Blizzard RM: Alterations in the pulsatile properties of circulating growth hormone concentration during puberty in boys, J Clin Endocrinol Metab 1989:69: 563-570.
4. Wennick JMB, Delcmare-van-de Waal HA, Schoemaker R, Blaau G, van den Braken C, Schoemaker J: Growth hormone secretion patterns in relation to LH and estradiol secretion throughout normal female puberty, J Clin Endocrinol Metab 1990; 124:129-135.
5. Faria ACS, Beckenstein LW, Booth RA, Vac-caro VA, Asplin CM, Veldhuis JD, Thorner MO: Pulsatile growth hormone release in normal women during the menstrual cycle, Clin Endocrinol 1992:36:591-596.
6. Ho K Y, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, Furlanetto R, Thorner MO: Effects of sex and age on the 24 hour secretory profile of GH secretion in man: Importance of endogenous estradiol concentrations, J Clin Endocrinol Metab 1987:64: 51-58.
7. Link K, Blizzard R, Evans W, Kaiser D, Parker M, Rogol A: The effect of androgens on the pulsatile release and the 24-hour mean concentration of growth hormone in pcripubcrtal males, J Clin Endocrinol Metab 1986:62: 159-164.
8. Liu L, Merriam GR, Sherins RJ: Chronic sex steroid exposure increases mean plasma growth hormone concentration and pulse amplitude in men with isolated hypogonado-tropic hypogonadism, J Clin Endocrinol Melab 1987:64:58.
9. Weissberger AJ, Ho KKY: Activation of the somatotropic axis by testosterone in adult males: Evidence for the role of aromatization, J Clin Endocrinol Metab 1993:76:1407-1412.
10. Ross JL, Meyerson Long L, Loriaux DL, Cutler GB: Growth hormone secretory dynamics in Turner syndrome, J Pedialr 1985:106: 202-206.
11. I I Mauras N, Rogol AD, Veldhuis JD: Specific, time-dependent actions of low-dose ethinyl estradiol administration on the episodic release of growth hormone, follicular-stimulating hormone and lutcinising hormone in prepubertal girls with Turner's syndrome, J Clin Endocrinol Metab 1989:69:1053-1058.
12. Ross JL, Cassorla FG, Skerda MC, Valk IM, Loriaux DL, Culler GB: A preliminary study of the effect of estrogen dose on growth in Turner's syndrome, N Engl J Med 1983:309: 1104-1106.
13. Copeland KC: Effects of acute high dose and chronic low dose estrogen on plasma somatomedin C and growth in patients with Ttimer's syndrome, J Clin Endocrinol Metab 1988:66: 1278-1282.
14. Wiedemann E, Schwartz E, Frantz A: Acute and chronic estrogen effects upon serum somatomedin activity, growth hormone, and prolactin in man, J Clin Endocrinol Metab 1976:42: 942-952.
15. Clemmons DR, Underwood LE, Ridgway EG, Kliman B, Kjellberg RN, Van Wyk JJ: Estradiol treatment of acromegaly: Reduction of immunoreactive somatomedin C and improvement of metabolic status, Am J Med 1980:69: 571-575.
16. Weissberger AJ, Ho KY, Lazarus L: Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I and Gil binding protein in postmenopausal women, J Clin Endocrinol Metab 1991;72:374-381.
17. Herington AC, Ymer S, Stevenson J: Identification and characterisation of specific binding proteins for growth hormone in normal human sera, J Clin Invest 1986;77:1817-1823.
18. Baumann G, Stolar MW, Amburn K, Barsano CP, DeVries BC: A specific growth hormone-binding protein in human plasma: Initial characterisation, J Clin Endocrinol Metab 1986:62: 134-141.
19. Leung DW, Spencer SA, Caehaincs G, Hammond RG, Collins C, Henzel WJ, Barnard R, Waters MJ, Wood WI: Growth hormone receptor and serum binding protein: Purification, cloning and expression, Nature 1987:330: 537-543.
20. Baumann G, Amburn KD, Buchanan TA: The effect of circulating growth hormone-binding protein on metabolic clearance, distribution and degradation of human growth hormone, J Clin Endocrinol Metab 1987:64:657-660.
21. D'Ercole AJ, Stiles AD, Underwood LE: Tissue concentrations of somatomedin C: Further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action, Proc Nall Acad Sci USA 1984:81:935-939.
22. de Lignieres B, Basdevant A, Thomas G: Biological effects of 17i estradiol in postmenopausal women: Oral versus percutaneous administration, J Clin Endocrinol Metab 1986: 62:536-541.
23. Chetkowski RJ, Meidrum DR, Steingold KA, Randle D, Lu JK, Eggena P, Hershman JM, Alkjaersig NK, Fletcher AP, Judd HL: Biological effects of transdermal estradiol, N Engt J Med 1986:314:1615-1620.
24. Ho KY, Valionlis E, Waters MJ, Rajkovie IA: Regulation of growth hormone binding protein in man: Comparison of gel chromatography and immunoprccipitation methods, J Clin Endocrinol Metab 1993:76:302-308.
25. Rajkovie IA, Valionlis E, Ho KKY: Direct quantitation of growth hormone binding protein in human serum by a ligand immunofunc-lional assay: Comparison with immunoprecip-itation and chromatography methods, J Clin Endocrinol Metab 1994:78:772-777.
26. Dawson-Hughes B, Stem D, Goldman J, Reiehlin S: Regulation of growth hormone and somalomedin-C secretion in postmenopausal women: Effect of physiological estrogen replacement, J Clin Endocrinol Metab 1986:63: 424-432.
27. Duursma S, Bijlsma J, Van Paassen II, van Buul-Offers S, Skottner-Lundin A: Changes in scrum somatomedin and grow'th hormone concentrations after 3 weeks oestrogen substitution in post-menopausal women: A pilot study, Acta Endocrinol 1984:106:527-531.
28. Murphy LJ, Freisen HG: Differential effects of estrogen and growth hormone on uterine and hepatic insulin-like growth factor-1 expression in the ovarieclomised hypophyseclomised rat, Endocrinology 1988; 122:325-332.
29. Mannor DA, Winer LM, Shaw VIA, Baumann G: Plasma growth hormone binding proteins: Effects on growth hormone binding to receptors and on growth hormone action, J Clin Endocrinol Metab 1991:73:30-34.
30. Uni E, Spencer SA, McKay P, Waters MJ: Regulation of growth hormone (GH l bioactivity by a recombinant human GH-hinding protein, Endocrinology 1990:127:1287-1291.
31. Baruch Y, Amit TPH, Enat R, Youdim MBH, Hochberg Z: Decreased serum growth hormone-binding protein in patients with liver cirrhosis, J Clin Endocrinol Metab 1991:73: 777-780.
32. Bellantoni MF, Harman M, Cho DE, Blackman MR: Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-1 in postmenopausal women, 1991:72:172-178.
33. Maschak CA, Lobo R, Dozono TR, Eggena P, Nakamura RM, Brenner PF, Mishell DR: Comparison of pharmacokinetic properties of various estrogen formulations, Am J Obslct Gynecol 1982:144:511-518.
34. Goebelsmann U, Maschak CA, Mishell DR: Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol, Am J Obstet Gynecol 1985:151:868-877.
35. Kelly JJ, Rajkovic IA, O'Sullivan AJ, Sernia C, Ho KKY: Effects of different oestrogen formulations on insulin-like growth factor-1. growth hormone and growth hormone binding protein in post-menopausal women, Clin Endocrinol 1993:39:561-567.
36. Mandel FP, Geola FL, Lu J, Eggena P, Sambhi MP, Hershman JM, Judd HE: Biological effects of various doses of ethinyl estradiol, Am J Obstet Gynecol 1982:59:673-679.
37. Baumann G, Shaw MA, Amburn K: Regulation of plasma growth hormone-binding proteins in health and disease, Metabolism 1989; 38:683-689.
38. Clark RG, Cunningham IF, Moore JA, Mulker-rin MG, Carlsson LMS, Spencer SA, Wood WI, Cronin MJ: Growth hormone binding protein enhances growth promoting activity of GH in the rat, Proc 73rd Meet EndocrSoc, Washington, 1991. p 433 (abstract)
39. Baumann G, Shaw MA, Merimee TJ: Low levels of high-affinily growth hormone binding protein in African pigmies, N Engl J Med 1989:320:1705-1709.
40. Daughaday WH, Trivodi B, Andrews BA: The ontogeny of serum GH binding protein in man: A possible indicator of Gil receptor development, J Clin Endocrinol Metab 1987:65: 1072-1074.
41. Carey D, Goldberg B, Ratzan S, Rubin K, RoweD: Radioimmunoassay for type I procollagen in growth hormone-deficient children before and during treatment with growth hormone, Pediatr Res 1985; 19:8-11.
42. Tapanainen P, Ristelli L, Knip M, Kaar M, Ris-tclli J: Serum aminotcrminal propeptide of type III procollagen: A potential predictor of the response to growth hormone therapy, J Clin Endocrinol Metab 1988:67:1244-1249.
43. Redder MM, Nissley SP, Podskalny JM, Moses AC, Fryklund L: Identification of a receptor for somatomedin-like polypeptides in human fibroblasts, J Clin Endocrinol Metab 1977:44:820-827.
44. Bennett A, Chen T, Feldman D, Hintz R, Rosenfeld R: Characterization of insulin-like growth factor I receptors on cultured rat bone cells: Regulation of receptor concentration by glucocorticoids, Endocrinology 1984:115:1577-1583.
45. Ho KKY, Weissberger AJ: Impact of shortterm estrogen administration on growth hormone secretion and action: Distinct route-dependent effects on connective and bone tissue metabolism, J Bone Miner Res 1992:7: 821-827.
46. Daughaday W, Rotwein P: Insulin-like growth factors I and II, Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations, Endocr Rev 1989;10:68-91.
47. Isaksson O, Eden S, Jansson JO: Mode of action of pituitary growth hormone on target cells, Annu Rev Physiol 1985:47:483-199.
48. Cook JJ, Haynes KM, Werther GA: Mitogcnic effects of growth hormone in cultured human fibroblasts, J Clin Invest 1988:81:206-212.
49. Barnard R, Ng K, Martin T, Waters M: Growth hormone (GH) receptors in clonal osteoblastlike cells mediate a mitogenic response, Endocrinology 1991:128:1459-1464.
50. Lindahl A, isgaard J, Nilsson A, Isaksson O: Growth hormone potentiates colony formation of epiphyseal chondrocytes in suspension culture, Endocrinology 1986:5:1843-1848.
51. Riza RA, Mandarino LJ, Gerich JE: Effcctsof growth hormone on insulin action in man, Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization, Diabetes 1982:31:663-669.
52. Ho KKY, Jenkins AB, Furler SM, Borkman M, Chisholm DJ: Impact of octreotide, a long-acting somatostatin analogue, on glucose tolerance and insulin sensitivity in acromegaly, Clin Endocrinol 1992:36:271-279.
53. O'Sullivan AJ, Ho KKY: A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women, J Clin Endocrinol Metab 1995:80:1783-1788.